EOLS Q2 2019 Earnings — Evolus, Inc. Revenue & Financial Results | Market Cap Arena

EOLSEvolus, Inc.

$338M

Q2 2019 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$2M

Gross Profit

$2M71.4% margin

Operating Income

-$36M-1557.6% margin

Net Income

-$38M-1625.6% margin

EPS (Diluted)

$-1.37

QoQ Revenue Growth

+Infinity%

Cash Flow

Operating Cash Flow

-$33M

Free Cash Flow

-$35M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$203M

Total Liabilities

$162M

Stockholders' Equity

$41M

Cash & Equivalents

$30M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$0	—
Gross Profit	$2M	$0	—
Operating Income	-$36M	-$16M	-123.6%
Net Income	-$38M	-$16M	-128.6%